Automated Closed Cell Processing System De-Risks Gene-Edited CD34+ Hematopoietic Stem Cell Manufacturing […]
Read More… from Bioprocess International – 2022 – Poster Presentation CT11
Publication Type: Poster Presentation
ISMB – 2022 – Poster Presentation 859
TransACT enhances detection and characterization of translocation events from high-throughput sequencing data at base-pair resolution for gene editing products […]
EHA – 2022 – Poster Presentation 1429
Multiplex Deletion of Myeloid Antigens CD33 and CLL-1 by CRISPR/Cas9 in Human Hematopoietic Stem Cells Highlights the Potential of Next-Generation Transplantation for AML Treatment […]
ASGCT – 2022 – Poster Presentation Tu-117
A Novel Scalable Electroporation Platform for the Manufacturing of Gene Modified Hematopoietic Stem and Progenitor Cell Therapies […]
ISGCT – 2022 – Poster Presentation 933
Novel Automated, Functionally Closed System for Rapid Immunomagnetic Negative Selection of T Cells […]
Keystone Symposia – 2022 – Poster Presentation 3002
Multiplex Editing of Hematopoietic Stem and Progenitor Cells (HSPCs) with CRISPR Cas Nucleases Achieves High On Target Editing with Undetectable Translocations […]
Read More… from Keystone Symposia – 2022 – Poster Presentation 3002
Keystone Symposia – 2022 – Poster Presentation 3001
Multiplex Base Editing in Human Hematopoietic Stem and Progenitor Cells (HSPCs) Enables Efficient Removal of Multiple Surface Antigens in Acute Myeloid Leukemia (AML) Immunotherapy […]
Read More… from Keystone Symposia – 2022 – Poster Presentation 3001
ASH Annual Meeting 2021 – Poster Presentation 1716
G-CSF/Plerixafor Dual-Mobilized Donor Derived CD33CAR T-Cells as Potent and Effective AML Therapy in Pre-Clinical Models […]
Read More… from ASH Annual Meeting 2021 – Poster Presentation 1716
ASH Annual Meeting 2021 – Poster Presentation 2939
Multiplex Engineering of Human CD34+ HSPCs Enables Dual Gene Knockout While Maintaining High Engraftment Potential and Safety […]
Read More… from ASH Annual Meeting 2021 – Poster Presentation 2939